Idelalisib

Category: Cancer

Idelalisib Overview

Idelalisib (trade name Zydelig zye-DEL-ig,[2] codenamed GS-1101 or CAL-101) is a drug used for the treatment of certain hematological malignancies. The substance acts as a phosphoinositide 3-kinase inhibitor; more specifically, it blocks P110δ, the delta isoform of the enzyme phosphoinositide 3-kinase.[3][4] It was developed by Gilead Sciences. Contents 1 Medical uses 2 Clinical trials 3 Adverse effects 4 Pharmacology 4.1 Mechanism of ...

Read more Idelalisib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Idelalisib

Recent Idelalisib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Idelalisib or a similar ingredient: (1 result)

• ZYDELIG Idelalisib